Could placental stem cell vesicles ease COVID-19?
Symptom relief
Not yet recruiting
This early-stage trial tests a single IV dose of placental stem cell vesicles (XoGlo Pro) against placebo in 64 adults with mild to moderate COVID-19. The main goal is safety, with a secondary focus on how quickly symptoms resolve. Researchers aim to see if these tiny cell partic…
Phase: PHASE1, PHASE2 • Sponsor: Kimera Labs Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC